Darbepoetin alfa administered every other week maintains hemoglobin levels over 52 weeks in patients with chronic kidney disease converting from once-weekly recombinant human erythropoietin: results from simplify the treatment of anemia with Aranesp (STAAR).
Am J Nephrol
; 26(2): 149-56, 2006.
Article
en En
| MEDLINE
| ID: mdl-16636531
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Hemoglobinas
/
Eritropoyetina
/
Anemia
/
Fallo Renal Crónico
Tipo de estudio:
Clinical_trials
/
Etiology_studies
Límite:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Am J Nephrol
Año:
2006
Tipo del documento:
Article
País de afiliación:
Estados Unidos